Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGMN | Q99538 | 4/20 | 0.67 |
| ▸ | GAA | P10253 | 4/20 | 0.61 |
| ▸ | RAD52 | P43351 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 10/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.58 |
| ▸ | TP53 | P04637 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | HTT | P42858 | 3/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | MITF | O75030 | 1/20 | 0.50 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2951905 | 0.98 | LGMN (0.65) | LGMNGAARAD52MAPTALDH1A1 | |
| SCHEMBL15358759 | 0.87 | GAA (0.77) | LGMNGAARAD52MAPTALDH1A1 | |
| SCHEMBL6151434 | 0.87 | GAA (0.77) | LGMNGAARAD52MAPTALDH1A1 | |
| SCHEMBL30545196 | 0.86 | LGMN (0.62) | LGMNGAARAD52MAPTALDH1A1 | |
| SCHEMBL375628 | 0.86 | LGMN (0.62) | LGMNGAARAD52MAPTALDH1A1 | |
| SCHEMBL19648924 | 0.84 | LGMN (0.53) | LGMNGAARAD52MAPTALDH1A1 | |
| SCHEMBL904452 | 0.83 | LGMN (0.73) | LGMNGAAMAPTALDH1A1KDM4E | |
| SCHEMBL7032717 | 0.83 | GAA (0.67) | LGMNGAARAD52MAPTALDH1A1 | |
| SCHEMBL2923577 | 0.83 | GAA (0.67) | LGMNGAARAD52MAPTALDH1A1 | |
| SCHEMBL1911932 | 0.83 | MAPT (0.69) | LGMNGAAMAPTALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2050749-B1 | PYRIMIDINE DERIVATIVE AS PI3K INHIBITOR AND USE THEREOF | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2017-11-22 | — | — | EP | claimed |
| US-20100069629-A1 | PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2010-03-18 | — | — | US | claimed |
| EP-2050749-A1 | PYRIMIDINE DERIVATIVE AS PI3K INHIBITOR AND USE THEREOF | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2009-04-22 | — | — | EP | claimed |
| US-20250263404-A1 | AMINOPYRIDINES AS ACTIVATORS OF PI3 KINASE | UCL BUSINESS LTD (GB) | 2025-08-21 | — | — | US | disclosed |
| US-RE50082-E1 | (5,6-dihydro)pyrimido[4,5-e]indolizines | NETHERLANDS TRANSLATIONAL RESEARCH CENTER B.V. (NL) | 2024-08-20 | — | — | US | disclosed |
| EP-4402127-A1 | AMINOPYRIDINES AS ACTIVATORS OF PI3 KINASE | UCL Business Ltd (GB) | 2024-07-24 | — | — | EP | disclosed |
| US-20230365559-A1 | NOVEL AMINOPYRIDINES AND THEIR USE IN TREATING CANCER | AUCKLAND UNISERVICES LIMITED (NZ) | 2023-11-16 | — | — | US | disclosed |
| EP-3966207-B1 | PHENYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF | DECIPHERA PHARMACEUTICALS LLC (US) | 2023-11-01 | — | — | EP | disclosed |
| EP-4217357-A1 | NOVEL AMINOPYRIDINES AND THEIR USE IN TREATING CANCER | Auckland Uniservices Limited (NZ) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023041905-A1 | AMINOPYRIDINES AS ACTIVATORS OF PI3 KINASE | UCL BUSINESS LTD (GB) | 2023-03-23 | — | — | WO | disclosed |
| CN-111217816-B | FLT3 kinase inhibitor and preparation and application thereof | 中国科学院上海药物研究所 | 2022-08-16 | — | — | CN | disclosed |
| EP-0181728-A2 | Light-sensitive silver halide photographic material | KONICA CORPORATION (JP) | 1986-05-21 | — | — | EP | disclosed |
| US-4581327-A | CORE AND SHELL STRUCTURES, RHODIUM DOPED SHELLS, HARDNESS OF TONE, STORAGE STABILITY | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1986-04-08 | — | — | US | disclosed |
| EP-0146302-A1 | Light-sensitive silver halide photographic material for direct-post and method for processing the same | KONICA CORPORATION (JP) | 1985-06-26 | — | — | EP | disclosed |
| US-4444875-A | LAYER OF A TETRAZOLIUM COMPOUND | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1984-04-24 | — | — | US | disclosed |
| US-4329417-A | OXIDIZERS AND QUATERNARY AMMONIUM SALTS, PHOSPHONIUM SALTS OR SULFONIUM SALTS | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1982-05-11 | — | — | US | disclosed |
| US-4233399-A | Photographic elements containing amino-substituted hydroxy-pyridones | CIBA-GEIGY AKTIENGESELLSCHAFT (CH) | 1980-11-11 | — | — | US | disclosed |
| US-4211835-A | TETRAZOLIUM COMPOUND, BLACK AND WHITE, HIGH CONTRAST | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1980-07-08 | — | — | US | disclosed |
| US-4192682-A | NON-DIFFUSIBLE COMPOUND HAVING OXIDATION POWER ON A HYDROQUINONE DEVELOPING AGENT; DEVELOPER CONTAINING NO HYDROQUINONE | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1980-03-11 | — | — | US | disclosed |
| US-4182886-A | OPTICAL FILTERS IN COLOR PHOTOGRAPHY | CIBA-GEIGY AKTIENGESELLSCHAFT (CH) | 1980-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069629-A1 | PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF | PIK3CA, AKT3, AKT1 | LGMN 4876/4885GAA 2827/4885RAD52 2095/4885 |
| US-20230365559-A1 | NOVEL AMINOPYRIDINES AND THEIR USE IN TREATING CANCER | DCK, DTYMK, TYMP | LGMN 4515/4885GAA 2100/4885RAD52 791/4885 |
| US-20250263404-A1 | AMINOPYRIDINES AS ACTIVATORS OF PI3 KINASE | PIK3CD, PTEN, PIK3CG | LGMN 4181/4885GAA 882/4885RAD52 4631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.